The following pages link to ACE inhibitor (Q288280):
Displaying 50 items.
- zofenopril (Q218284) (← links)
- perindopril (Q277785) (← links)
- lisinopril (Q412208) (← links)
- ramipril (Q412666) (← links)
- aliskiren (Q414904) (← links)
- captopril (Q421119) (← links)
- enalapril (Q422185) (← links)
- fosinopril (Q425293) (← links)
- benazepril (Q592802) (← links)
- quinapril (Q596022) (← links)
- spirapril (Q835757) (← links)
- trandolapril (Q929420) (← links)
- imidapril (Q1041804) (← links)
- delapril (Q1164067) (← links)
- moexipril (Q2291605) (← links)
- type 2 diabetes (Q3025883) (← links)
- alacepril (Q3290792) (← links)
- discovery and development of ACE inhibitors (Q5281992) (← links)
- Category:ACE inhibitors (Q6261730) (← links)
- omapatrilat (Q7089596) (← links)
- quinaprilat (Q7272073) (← links)
- rentiapril (Q7313544) (← links)
- teprotide (Q7701390) (← links)
- The Effects of Angiotensin Converting Enzyme Inhibitors (ACE-I) on Human N-Acetyl-Seryl-Aspartyl-Lysyl-Proline (Ac-SDKP) Levels: A Systematic Review and Meta-Analysis (Q26776514) (← links)
- benazeprilat (Q27075017) (← links)
- cilazaprilat (Q27076049) (← links)
- fosinoprilat (Q27077720) (← links)
- perindoprilat (Q27088302) (← links)
- ramiprilat (Q27088514) (← links)
- enalaprilat dihydrate (Q27126932) (← links)
- val-pro-pro (Q27143860) (← links)
- mk-351a (Q27236614) (← links)
- cilazapril monohydrate (Q27252108) (← links)
- temocapril hydrochloride (Q27270390) (← links)
- libenzapril (Q27287204) (← links)
- ceronapril (Q27293516) (← links)
- imidaprilat (Q27888346) (← links)
- Spotlight on valsartan-sacubitril fixed-dose combination for heart failure: the evidence to date (Q28070064) (← links)
- Angiotensin receptor-neprilysin inhibitors: clinical potential in heart failure and beyond (Q28088583) (← links)
- Screening and management of coronary artery disease in diabetic patients (Q28213510) (← links)
- Renin-angiotensin system blockade for the risk of cancer and death (Q30249043) (← links)
- The effect of combination treatment with aliskiren and blockers of the renin-angiotensin system on hyperkalaemia and acute kidney injury: systematic review and meta-analysis (Q34122611) (← links)
- Effects of ACEI/ARB in hypertensive patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled studies (Q34459963) (← links)
- Renin angiotensin system inhibitors for patients with stable coronary artery disease without heart failure: systematic review and meta-analysis of randomized trials (Q34549694) (← links)
- Is angiotensin-converting enzyme inhibitors/angiotensin receptor blockers therapy protective against prostate cancer? (Q36916329) (← links)
- Peripheral artery disease: potential role of ACE-inhibitor therapy (Q37428854) (← links)
- Neprilysin inhibition in chronic kidney disease (Q38241522) (← links)
- Current evidence on the use of anti-RAAS agents in congenital or acquired solitary kidney (Q38626226) (← links)
- Angiotensin II Receptor Blockers and Cancer Risk: A Meta-Analysis of Randomized Controlled Trials (Q38826605) (← links)
- Efficacy of Treatment of Non-hereditary Angioedema (Q38965393) (← links)